Ampio Pharmaceuticals, Inc. (AMPE)


Stock Price Forecast

April 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Ampio Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for Ampio Pharmaceuticals, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

19

Exchange

NYSE

$0M

Total Revenue

19

Employees

$1M

Market Capitalization

-0.13

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AMPE News

Ampio Pharmaceuticals Inc AMPE

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

15d ago, source: Yahoo Finance

ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed in its Annual Report on ...

Ampio Announces Voluntary Delisting and SEC Deregistration

24d ago, source: Yahoo Finance

ENGLEWOOD, Colo., March 25, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that its Board of Directors determined to voluntarily ...

AMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023

on MSN ago, source:

Ampio Pharmaceuticals (NYSEMKT:AMPE) just reported results for the fourth quarter of 2023. Ampio Pharmaceuticals reported ...

Ampio Pharmaceuticals to delist from NYSE American

23d ago, source: Investing

ENGLEWOOD, Colo. - Ampio Pharmaceuticals (NYSE:AMPE), Inc. (NYSE American: AMPE) announced today its decision to voluntarily delist its common stock from the NYSE American. The pharmaceutical company ...

Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

14d ago, source: KTLA

View original content to download multimedia:https://www.prnewswire.com/news-releases/ampio-pharmaceuticals-received-audit-opinion-with-going-concern-explanation ...

Ampio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC Deregistration

23d ago, source: Finanznachrichten

ENGLEWOOD, Colo., March 25, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that its Board of Directors determined to voluntarily ...

Ampio Pharmaceuticals Inc

24d ago, source: U.S. News & World Report

Are Financial Advisors Worth It? Beyond stock picking, today's advisors help clients plan for a wide range of financial and life goals.

Ampio Pharmaceuticals Inc.

27d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...